Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$72.2K Buy
1,651
+1,623
+5,796% +$68.9K ﹤0.01% 1752
2026
Q2
$1.1K Hold
28
– – ﹤0.01% 3127
2026
Q1
$1.12K Buy
+28
New +$1.32K ﹤0.01% 3015
2025
Q1
– Sell
-175
Closed -$8.02K – 2739
2024
Q4
$8.02K Buy
+175
New +$7.84K ﹤0.01% 1837
2024
Q1
– Sell
-10
Closed -$478 – 2080
2023
Q4
$478 Buy
+10
New +$425 ﹤0.01% 1682
2023
Q2
– Sell
-787
Closed -$38.3K – 1660
2023
Q1
$38.3K Buy
787
+232
+42% +$11.8K ﹤0.01% 1092
2022
Q4
$29.4K Buy
555
+155
+39% +$7.64K ﹤0.01% 1143
2022
Q3
$18K Sell
400
-39
-9% -$1.93K ﹤0.01% 1147
2022
Q2
$22K Buy
439
+127
+41% +$6.2K ﹤0.01% 1107
2022
Q1
$16K Buy
+312
New +$16.1K ﹤0.01% 1114
2018
Q4
– Sell
-958
Closed -$38K – 1517
2018
Q3
$38K Sell
958
-67
-7% -$2.68K ﹤0.01% 803
2018
Q2
$39K Sell
1,025
-134
-12% -$4.93K ﹤0.01% 777
2018
Q1
$40K Sell
1,159
-251
-18% -$8.81K ﹤0.01% 792
2017
Q4
$46K Sell
1,410
-18
-1% -$620 ﹤0.01% 811
2017
Q3
$48K Sell
1,428
-116
-8% -$4K ﹤0.01% 713
2017
Q2
$55K Sell
1,544
-11
-0.7% -$371 ﹤0.01% 660
2017
Q1
$48K Buy
+1,555
New +$47.9K ﹤0.01% 650

Other funds holding QGEN

AssetMark's QGEN Position: Q3 2026 in Review

AssetMark increased its Qiagen (QGEN) stake by 5,796% in Q3 2026, buying an estimated $68.9K and bringing the position to 1,651 shares worth $72.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1752.

AssetMark first reported a position in QGEN in Q1 2017 and has held it in 17 quarters since. 280 funds tracked by Wall St. Rank hold QGEN as of Q3 2026.

  • AssetMark held 1,651 shares of Qiagen worth $72.2K as of Q3 2026.
  • AssetMark bought 1,623 Qiagen shares in Q3 2026, an estimated $68.9K.
  • Qiagen made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #1752 holding.
  • AssetMark first reported a position in Qiagen in Q1 2017 and has held it in 17 quarters since.
  • 280 funds tracked by Wall St. Rank held Qiagen as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.